TY - JOUR
T1 - Adipocyte (Pro)Renin-Receptor Deficiency Induces Lipodystrophy, Liver Steatosis and Increases Blood Pressure in Male Mice
AU - Wu, Chia Hua
AU - Mohammadmoradi, Shayan
AU - Thompson, Joel
AU - Su, Wen
AU - Gong, Ming
AU - Nguyen, Genevieve
AU - Yiannikouris, Frédérique
N1 - Publisher Copyright:
© 2016 American Heart Association, Inc.
PY - 2016/7/1
Y1 - 2016/7/1
N2 - Adipose tissue dysfunction related to obesity is overwhelmingly associated with increased risk of developing cardiovascular diseases. In the setting of obesity, (pro)renin receptor (PRR) is increased in adipose tissue of mice. We sought to determine the physiological consequences of adipocyte-PRR deficiency using adiponectin-Cre mice. We report a unique model of adipocyte-PRR-deficient mice (PRRAdi/Y) with almost no detectable white adipose tissues. As a consequence, the livers of PRRAdi/Y mice were enlarged and demonstrated a marked accumulation of lipids. Adipocyte-specific deficiency of PRR increased systolic blood pressure and the concentration of soluble PRR in plasma. To determine whether adipocyte-PRR was involved in the development of obesity-induced hypertension, mice were fed a low-fat or a high-fat diet for 16 weeks. Adipocyte-PRR-deficient mice were resistant to diet-induced obesity. Both high-fat- and low-fat-fed PRRAdi/Y mice had elevated insulin levels. Interestingly, adipocyte-PRR deficiency improved glucose tolerance in high-fat-fed PRRAdi/Y mice. In response to feeding either low-fat or high-fat diets, systolic blood pressure was greater in PRRAdi/Y mice than in control mice. High-fat feeding elevated soluble PRR concentration in control and PRRAdi/Y mice. In vitro knockdown of PRR by siRNA significantly decreased mRNA abundance of PPARγ (peroxisome proliferator-activated receptor gamma), suggesting an important role for PRR in adipogenesis. Our data indicate that adipocyte-PRR is involved in lipid homeostasis and glucose and insulin homeostasis, and that soluble PRR may be a predictor of metabolic disturbances and play a role in systolic blood pressure regulation.
AB - Adipose tissue dysfunction related to obesity is overwhelmingly associated with increased risk of developing cardiovascular diseases. In the setting of obesity, (pro)renin receptor (PRR) is increased in adipose tissue of mice. We sought to determine the physiological consequences of adipocyte-PRR deficiency using adiponectin-Cre mice. We report a unique model of adipocyte-PRR-deficient mice (PRRAdi/Y) with almost no detectable white adipose tissues. As a consequence, the livers of PRRAdi/Y mice were enlarged and demonstrated a marked accumulation of lipids. Adipocyte-specific deficiency of PRR increased systolic blood pressure and the concentration of soluble PRR in plasma. To determine whether adipocyte-PRR was involved in the development of obesity-induced hypertension, mice were fed a low-fat or a high-fat diet for 16 weeks. Adipocyte-PRR-deficient mice were resistant to diet-induced obesity. Both high-fat- and low-fat-fed PRRAdi/Y mice had elevated insulin levels. Interestingly, adipocyte-PRR deficiency improved glucose tolerance in high-fat-fed PRRAdi/Y mice. In response to feeding either low-fat or high-fat diets, systolic blood pressure was greater in PRRAdi/Y mice than in control mice. High-fat feeding elevated soluble PRR concentration in control and PRRAdi/Y mice. In vitro knockdown of PRR by siRNA significantly decreased mRNA abundance of PPARγ (peroxisome proliferator-activated receptor gamma), suggesting an important role for PRR in adipogenesis. Our data indicate that adipocyte-PRR is involved in lipid homeostasis and glucose and insulin homeostasis, and that soluble PRR may be a predictor of metabolic disturbances and play a role in systolic blood pressure regulation.
KW - adipocytes
KW - blood pressure
KW - glucose
KW - insulin
KW - lipids
KW - prorenin receptor
UR - http://www.scopus.com/inward/record.url?scp=84966784611&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84966784611&partnerID=8YFLogxK
U2 - 10.1161/HYPERTENSIONAHA.115.06954
DO - 10.1161/HYPERTENSIONAHA.115.06954
M3 - Article
C2 - 27185751
AN - SCOPUS:84966784611
SN - 0194-911X
VL - 68
SP - 213
EP - 219
JO - Hypertension
JF - Hypertension
IS - 1
ER -